Additionally, research has shown evidence for the existence of a TG2/NF-κB signaling loop in breast cancer, the nature of the signal transduction that activates this loop, and phenotypic consequences stemming from its aberrant activation (Brown, 2013). The gene discussed is TGM2; the disease is breast cancer.